Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

Peter Ferenci; Florin A. Caruntu; Gabriella Lengyel; Diethelm Messinger; Georgios Bakalos; Robert Flisiak

doi:10.1007/s40121-016-0110-5

Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

Infectious Diseases and Therapy ◽

10.1007/s40121-016-0110-5 ◽

2016 ◽

Vol 5 (2) ◽

pp. 113-124 ◽

Cited By ~ 2

Author(s):

Peter Ferenci ◽

Florin A. Caruntu ◽

Gabriella Lengyel ◽

Diethelm Messinger ◽

Georgios Bakalos ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Phase Iiib ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study

Journal of Gastroenterology ◽

10.1007/s00535-015-1120-x ◽

2015 ◽

Vol 51 (4) ◽

pp. 390-403 ◽

Cited By ~ 15

Author(s):

Norio Hayashi ◽

Makoto Nakamuta ◽

Tetsuo Takehara ◽

Hiromitsu Kumada ◽

Akiko Takase ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Japanese Patients ◽

Phase Iii ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve ◽

Phase Iii Study ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718025097.793482339 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Randomized Controlled Trial ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Genotype 1 ◽

Virus Genotype ◽

Randomized Controlled ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718025097.793482741 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Randomized Controlled Trial ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Genotype 1 ◽

Virus Genotype ◽

Randomized Controlled ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

466 PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 WHEN TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR)

Journal of Hepatology ◽

10.1016/s0168-8278(11)60468-6 ◽

2011 ◽

Vol 54 ◽

pp. S190 ◽

Cited By ~ 13

Author(s):

K.R. Reddy ◽

S. Bruno ◽

L. Rossaro ◽

N. Ravendhran ◽

M.P. Pauly ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

Predictors of Sustained Virologic Response Among Treatment-NaïVE Patients With Hepatitis C Virus Genotype 1 When Treated With Boceprevir (Boc) Plus Peginterferon Alfa-2B-Ribavirin (PR)

Gastroenterology ◽

10.1016/s0016-5085(11)63910-3 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-943 ◽

Cited By ~ 1

Author(s):

Rajender Reddy ◽

Savino Bruno ◽

Lorenzo Rossaro ◽

Natarajan Ravendhran ◽

Mary Pat Pauly ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection

Gastroenterology ◽

10.1053/j.gastro.2013.06.051 ◽

2013 ◽

Vol 145 (4) ◽

pp. 790-800.e3 ◽

Cited By ~ 19

Author(s):

Patrick Marcellin ◽

Curtis Cooper ◽

Luis Balart ◽

Dominique Larrey ◽

Terry Box ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Trial ◽

Genotype 1 ◽

Virus Genotype ◽

Randomized Controlled ◽

Treatment Naïve ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718196356.793490906 ◽

2014 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Low Dose ◽

Pegylated Interferon ◽

Genotype 1 ◽

Virus Genotype ◽

Interferon Α2a ◽

Treatment Naïve

Download Full-text

P1233 EFFICACY AND SAFETY OF MK-5172 PLUS RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: FINAL RESULTS OF THE C-SPIRIT STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(14)61393-3 ◽

2014 ◽

Vol 60 (1) ◽

pp. S499 ◽

Cited By ~ 1

Author(s):

E. Gane ◽

Z. Ben Ari ◽

L. Mollison ◽

E. Zuckerman ◽

R. Bruck ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Efficacy And Safety ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve

Download Full-text

A Double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-infected

Liver International ◽

10.1111/liv.12334 ◽

2013 ◽

Vol 34 (6) ◽

pp. e89-e95 ◽

Cited By ~ 5

Author(s):

Stephen Gardner ◽

Amy Cutrell ◽

Cindy Elko-Simms ◽

Kimberly Adkison ◽

Robert Hamatake ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Activity ◽

Controlled Study ◽

Genotype 1 ◽

Virus Genotype ◽

Double Blind ◽

Peginterferon Alfa

Download Full-text

Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon-??-2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1

PharmacoEconomics ◽

10.2165/00019053-200523100-00007 ◽

2005 ◽

Vol 23 (10) ◽

pp. 1043-1055 ◽

Cited By ~ 15

Author(s):

Maria Buti ◽

Miguel A Casado ◽

Leslie Fosbrook ◽

Rafael Esteban

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virological Response ◽

Financial Impact ◽

Early Virological Response ◽

Genotype 1 ◽

Virus Genotype ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve

Download Full-text